Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T19:07:23.803Z.
Calculation as of: 2026-10-06T19:07:23.803Z.
Quote observation: 2026-10-06T19:05:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 55b8dbabd3995de6814355fb2a21bc992d842325745fe4a48a34f8d646fc1b47
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$4.68B
EBITDA Yield
2.86%
TTM Avg
2.61%
3Y Avg
2.07%
5Y Avg
1.96%
Market Cap
$4.65B
EBITDA Yield
7.16%
TTM Avg
7.73%
3Y Avg
6.77%
5Y Avg
5.88%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.81B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.83B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.70B | N/A | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 2.86% | 2.61% | 2.07% | 1.96% |
| BillionToOne, Inc. (BLLN)vs › | $4.67B | 1.30% | 0.79% | 0.79% | 0.79% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 7.16% | 7.73% | 6.77% | 5.88% |
| Erasca, Inc. (ERAS)vs › | $4.94B | N/A | N/A | N/A | N/A |
| Waystar Holding Corp. (WAY)vs › | $5.00B | 6.68% | 6.48% | 5.36% | 5.36% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.05B | 6.22% | 6.37% | 5.19% | 4.76% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2026-05-06 | 0.04% |
| 2026-05-05 | 0.04% |
| 2026-05-04 | 0.04% |
| 2026-05-01 | 0.04% |
| 2026-04-30 | 0.04% |
| 2026-04-29 | 0.04% |
| 2026-04-28 | 0.04% |
| 2026-04-27 | 0.05% |
| 2026-04-24 | 0.05% |
| 2026-04-23 | 0.05% |
| 2026-04-22 | 0.04% |
| 2026-04-21 | 0.04% |
| 2026-04-20 | 0.04% |
| 2026-04-17 | 0.04% |
| 2026-04-16 | 0.04% |
| 2026-04-15 | 0.04% |
| 2026-04-14 | 0.04% |
| 2026-04-13 | 0.04% |
| 2026-04-10 | 0.04% |
| 2026-04-09 | 0.04% |
| 2026-04-08 | 0.04% |
| 2026-04-07 | 0.04% |
| 2026-04-06 | 0.04% |
| 2026-04-02 | 0.04% |
| 2026-04-01 | 0.04% |
| 2026-03-31 | 0.05% |
| 2026-03-30 | 0.05% |
| 2026-03-27 | 0.05% |
| 2026-03-26 | 0.05% |
| 2026-03-25 | 0.05% |
| 2026-03-24 | 0.05% |
| 2026-03-23 | 0.05% |
| 2026-03-20 | 0.05% |
| 2026-03-19 | 0.05% |
| 2026-03-18 | 0.05% |
| 2026-03-17 | 0.04% |
| 2026-03-16 | 0.05% |
| 2026-03-13 | 0.05% |
| 2026-03-12 | 0.05% |
| 2026-03-11 | 0.05% |
| 2026-03-10 | 0.05% |
| 2026-03-09 | 0.05% |
| 2026-03-06 | 0.05% |
| 2026-03-05 | 0.05% |
| 2026-03-04 | 0.04% |
| 2026-03-03 | 0.05% |
| 2026-03-02 | 0.05% |
| 2026-02-27 | 0.05% |
| 2026-02-26 | 0.05% |
